Document:

August 15, 2019 S-8 Exhibit 4.3

EXHIBIT 4.3
 

SEELOS THERAPEUTICS, INC.

                  STOCK OPTION GRANT NOTICE AND

                  STOCK OPTION AGREEMENT

              (Time-Based Stock Option)

Seelos Therapeutics, Inc. (the "Company"), pursuant to its 2019 Inducement Plan (the
"Plan"), hereby grants to the holder listed below ("Participant"), an option to purchase the number of shares of the Company's Stock
("Stock") set forth below (the "Stock Option"). This Stock Option is subject to all of the terms and conditions set forth herein and in the
Stock Option Agreement attached hereto as Exhibit A (the "Stock Option Agreement") and the Plan, which are incorporated herein by reference. Unless
otherwise defined herein, the terms defined in the Plan shall have the same defined meanings in this Grant Notice and the Stock Option Agreement.

	
Participant:
	
_________________________________________________

	
Grant Date:
	
_________________________________________________

	
Vesting Commencement Date:
	
_________________________________________________

	
Exercise Price per Share of Stock:
	
$_________________________________________________

	
Total Exercise Price:
	
$_________________________________________________

	
Total Number of Shares of Stock Subject to the Stock Option:
	
 

___________________________________________ shares

	
Expiration Date:
	
_________________________________________________

 

Type of Option:           x 
    Non-Qualified Stock Option

	
Vesting Schedule:
	

25% of the total number of shares of Stock subject to the Stock Option shall vest on the first anniversary of the Vesting Commencement
Date, and 1/48th of the total number of shares of Stock subject to the Stock Option shall vest monthly thereafter, so that the Stock Option shall be fully vested on the
4th anniversary of the Vesting Commencement Date, provided that Participant does not have a termination of Employment prior to any such vesting date. 

By his or her signature, Participant agrees to be bound by the terms and conditions of the Plan, the Stock Option Agreement and this Grant Notice. Participant has
reviewed the Stock Option Agreement, the Plan and this Grant Notice in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Grant Notice and fully
understands all provisions of this Grant Notice, the Stock Option Agreement and the Plan. Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of
the Administrator upon any questions arising under the Plan, this Grant Notice or the Stock Option Agreement.

The Plan, this Grant Notice and the Stock Option Agreement constitute the entire agreement of the parties and supersede in their entirety all oral, implied or written
promises, statements, understandings, undertakings and agreements between the Company and Participant with respect to the subject matter hereof, including without limitation, the provisions
of any employment agreement or offer letter regarding equity awards to be awarded to Participant by the Company, or any other oral, implied or written promises, statements, understandings,
undertakings or agreements by the Company or any of its representatives regarding equity awards to be awarded to Participant by the Company.

	
SEELOS THERAPEUTICS, INC.
	
	
PARTICIPANT

	
By:
	_____________________________________________________
	 	
By:
	_____________________________________________________

	
Name:
	_____________________________________________________
	 	
Name:
	_____________________________________________________

	
Title:
	
_____________________________________________________
	 	 	 
	
Address:
	
300 Park Ave. 12th Floor 
	 	
Address:
	_____________________________________________________

	
	
New York, NY 10022
	
	
	_____________________________________________________

EXHIBIT A

                  TO STOCK OPTION GRANT NOTICE

STOCK OPTION AGREEMENT

Pursuant to the Stock Option Grant Notice (the "Grant Notice") to which this Stock Option Agreement (this
"Agreement") is attached, Seelos Therapeutics, Inc., (the "Company"), has granted to Participant a Stock Option under the Company's
2019 Inducement Plan (the "Plan") to purchase the number of shares of Stock indicated in the Grant Notice.

ARTICLE I

                      GENERAL

1.1   Defined Terms. Capitalized terms not specifically defined herein shall have the meanings specified in the Plan and the Grant Notice.

1.2   Incorporation of Terms of Plan. The Stock Option is subject to the terms and conditions of the Plan which are incorporated herein by reference. In the
event of any inconsistency between the Plan and this Agreement, the terms of the Plan shall control. 

ARTICLE II

                   GRANT OF OPTION

2.1   Grant of Option. In consideration of Participant's commencement of employment with the Company or an Affiliate and for other good and valuable
consideration, effective as of the Grant Date set forth in the Grant Notice (the "Grant Date"), the Company irrevocably grants to Participant the Stock Option to
purchase any part or all of an aggregate of the number of shares of Stock set forth in the Grant Notice, upon the terms and conditions set forth in the Plan, the Grant Notice and this Agreement.
The Stock Option shall be a non-qualified stock option.

2.2   Exercise Price. The exercise price of the shares of Stock subject to the Stock Option shall be as set forth in the Grant Notice, without commission or other
charge; provided, however, that the price per share of the shares of Stock subject to the Stock Option shall not be less than 100% of the fair market value of a share of Stock
on the Grant Date (as determined under Section 6(a)(10) of the Plan).

2.3   No Right to Continued Employment. Nothing in the Plan, the Grant Notice, or this Agreement shall confer upon Participant any right to continue in the
employ or service of the Company or any Affiliate or shall interfere with or restrict in any way the rights of the Company and any Affiliate, which rights are hereby expressly reserved, to
discharge or terminate the services of Participant at any time for any reason whatsoever, except to the extent expressly provided otherwise in a written agreement between the Company or an
Affiliate and Participant.

ARTICLE III

PERIOD OF EXERCISABILITY

3.1   Commencement of Exercisability.

	Subject to Sections 3.2, 3.3 and 5.6, the Stock Option shall become vested and exercisable in such amounts and at such times as are set forth in the Grant Notice.

                                                       A-1

	No portion of the Stock Option that has not become vested and exercisable at the date of Participant's termination of Employment shall thereafter become vested
and exercisable, except as may be otherwise provided in the Grant Notice or provided by the Administrator or as set forth in a written agreement between the Company and
Participant.

3.2   Duration of Exercisability. The installments provided for in the vesting schedule set forth in the Grant Notice are cumulative. Each such installment that
becomes vested and exercisable pursuant to the vesting schedule set forth in the Grant Notice shall remain vested and exercisable until it becomes unexercisable under Section 3.3.

3.3   Expiration of Option. The Stock Option may not be exercised to any extent by anyone after the first to occur of the following events:

	The expiration of ten years from the Grant Date; 

	The expiration of three months following the date of Participant's termination of Employment, unless such termination occurs by reason of Participant's death,
Disability (as defined below) or for Cause; 

	The expiration of one year from the date of Participant's death; 

	The expiration of one year from the date of Participant's termination of Employment by reason of Participant's Disability; or

	The date of Participant's termination of Employment by the Company for Cause. 

For purposes of this Agreement "Disability" shall have the meaning given to such term in Section 22(e)(3) of the Code.

ARTICLE IV

EXERCISE OF OPTION

4.1   Person Eligible to Exercise. Except as provided in Section 5.1, during the lifetime of Participant, only Participant may exercise the Stock Option or any
portion thereof. After the death of Participant, any exercisable portion of the Stock Option may, prior to the time when the Stock Option becomes unexercisable under Section 3.3, be exercised
by Participant's personal representative or by any person empowered to do so under the deceased Participant's will or under the then applicable laws of descent and distribution.

4.2   Partial Exercise. Any exercisable portion of the Stock Option or the entire Stock Option, if then wholly exercisable, may be exercised in whole or in part at
any time prior to the time when the Stock Option or portion thereof becomes unexercisable under Section 3.3.

4.3   Manner of Exercise. The Stock Option, or any exercisable portion thereof, may be exercised solely by delivery to the Secretary of the Company (or any
third-party administrator or other person or entity designated by the Company) of all of the following prior to the time when the Stock Option or such portion thereof becomes unexercisable
under Section 3.3:

                                                       A-2

	An Exercise Notice in writing signed by Participant or any other person then entitled to exercise the Stock Option or portion thereof, stating that the Stock Option or
portion thereof is thereby exercised, such notice complying with all applicable rules established by the Administrator. Such notice shall be substantially in the form attached as Exhibit
B to the Grant Notice (or such other form as is prescribed by the Administrator); 

	The receipt by the Company of full payment for the shares of Stock with respect to which the Stock Option or portion thereof is exercised, including payment of any
applicable withholding tax, as provided under Section 4.4 (subject to Section 6(a)(6) of the Plan); 

	Any other written representations as may be required in the Administrator's reasonable discretion to evidence compliance with the Securities Act or any other
applicable law, rule, or regulation; and

	In the event the Stock Option or portion thereof shall be exercised pursuant to Section 4.1 by any person or persons other than Participant, appropriate proof of the
right of such person or persons to exercise the Stock Option.

Notwithstanding any of the foregoing, the Company shall have the right to specify all conditions of the manner of exercise, which conditions may vary by country
and which may be subject to change from time to time.

4.4   Method of Payment. Payment of the exercise price and any applicable withholding tax shall be by any of the following, or a combination thereof, at the
election of Participant:

	Cash;

	Certified Check;

	Delivery of a notice that Participant has placed a market sell order with a broker with respect to shares of Stock then issuable upon exercise of the Stock Option,
and that the broker has been directed to pay a sufficient portion of the net proceeds of the sale to the Company in satisfaction of the aggregate exercise price of the shares of Stock with respect
to which the Stock Option or portion thereof is being exercised and any applicable withholding tax; provided, that payment of such proceeds is then made to the Company upon
settlement of such sale;

	With the consent of the Administrator, surrender of vested shares of Stock owned by Participant that have a fair market value on the date of surrender equal to the
aggregate exercise price of the shares of Stock with respect to which the Stock Option or portion thereof is being exercised and any applicable withholding tax;

	With the consent of the Administrator, surrendered shares of Stock issuable upon the exercise of the Stock Option having a fair market value on the date of exercise
equal to the aggregate exercise price of the shares of Stock with respect to which the Stock Option or portion thereof is being exercised and any applicable withholding tax; or

                                                       A-3

	Notwithstanding any other provision of the Plan or this Agreement, if Participant is a director or "executive officer" of the Company within the meaning of Section 13(k) of the
Securities Exchange Act of 1934, as amended (the "Exchange Act"), he or she shall not be permitted to make payment pursuant to this Section 4.4, or continue any
extension of credit with respect to such payment with a loan from the Company or a loan arranged by the Company, in violation of Section 13(k) of the Exchange Act. 

4.5   Conditions to Issuance of Stock Certificates. The Company shall not be required to issue or deliver any shares of Stock purchased upon the exercise of
the Stock Option or portion thereof prior to fulfillment of all of the following conditions:

	The satisfaction of all of the conditions set forth in Section 8 of the Plan; 

	The lapse of such reasonable period of time following the exercise of the Stock Option as the Administrator may from time to time establish for reasons of
administrative convenience; and

	The receipt by the Company of full payment for such shares of Stock, including payment of any applicable withholding tax, as provided under Section
4.4.

4.6   Rights as Stockholder. Participant shall not be, nor have any of the rights or privileges of, a stockholder of the Company in respect of any shares of Stock
purchasable upon the exercise of any part of the Stock Option unless and until such shares of Stock shall have been issued by the Company to such Participant (as evidenced by the
appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company) and, once issued, such shares of Stock shall be freely tradeable and non-forfeitable. No
adjustment will be made for a dividend or other right for which the record date is prior to the date the shares of Stock are issued, except as provided in Section 7 of the Plan. 

4.7   Other Forfeiture and Claw-Back Provisions.  Participant hereby acknowledges and agrees that the Option and any amounts issued or paid to Participant in
settlement of the Stock Option are subject to the provisions of Section 6(a)(5) of the Plan.

4.8   Trading Restrictions. 

	The Company may establish periods from time to time during which Participant's ability to engage in transactions involving the Company's Stock is subject to
specific restrictions ("Restricted Periods").  Notwithstanding any other provisions herein, Participant may not exercise Stock Options or sell or otherwise dispose of
any shares of Stock acquired pursuant to the Stock Option during an applicable Restricted Period unless such exercise is specifically permitted by the Company, in its sole discretion.
Participant may be subject to restrictions giving rise to a Restricted Period for any reason that the Company determines appropriate, including, restrictions generally applicable to employees or
groups of employees or restrictions applicable to Participant during an investigation of allegations of misconduct or conduct detrimental to the Company or any Affiliate by Participant.

	Participant acknowledges and agrees that the Stock Option and the shares of Stock  issuable upon exercise of the Stock Option, any other equity awards now held
by Participant or hereafter acquired by Participant, and any shares of Stock issuable upon exercise, vesting or settlement thereof, shall be subject to the terms and conditions of any stock
ownership or retention guidelines (the "Guidelines") adopted from time to time by the Company to the extent such Guidelines are by their terms

                                                       A-4

applicable to Participant.  Participant hereby acknowledges and agrees that the Administrator shall have the authority to review Participant's compliance (or progress towards compliance) with such
Guidelines from time to time and, in its sole discretion, to impose such conditions, restrictions or limitations on Participant, the  Stock Option, the shares of Stock issuable upon exercise of the
Stock Option, other equity awards held by Participant and other shares of Stock issuable upon exercise, vesting or settlement thereof as the Administrator determines to be necessary or
appropriate in order to achieve the purposes of such Guidelines.

ARTICLE V

OTHER PROVISIONS

5.1   Option Generally Not Transferable.

	Subject to Section 5.1(c), the Stock Option may not be sold, pledged, assigned or transferred in any manner other than by will or the laws of descent unless and
until the shares of Stock underlying the Stock Option have been issued, and all restrictions applicable to such shares of Stock have lapsed. Neither the Stock Option nor any interest or right
therein shall be liable for the debts, contracts or engagements of Participant or his or her successors in interest or shall be subject to disposition by transfer, alienation, anticipation, pledge,
encumbrance, assignment or any other means whether such disposition be voluntary or involuntary or by operation of law by judgment, levy, attachment, garnishment or any other legal or
equitable proceedings (including bankruptcy), and any attempted disposition thereof shall be null and void and of no effect, except to the extent that such disposition is permitted by the
preceding sentence.

	Unless transferred in accordance with Section 5.1(c), during the lifetime of Participant, only Participant may exercise the Stock Option or any portion thereof. After
the death of Participant, any exercisable portion of the Option may, prior to the time when the Stock Option becomes unexercisable under Section 3.3, be exercised by Participant's personal
representative or by any person empowered to do so under the deceased Participant's will or under the then applicable laws of descent and distribution.

	Notwithstanding any other provision in this Agreement, with the consent of the Administrator, the Stock Option may be transferred by gift, subject to
applicable securities and other laws and such other conditions and procedures as the Administrator may require. 

5.2   Adjustments. Participant acknowledges that the Stock Option, including the vesting of the Stock Option and the number of shares of Stock subject to the
Stock Option, is subject to adjustment in the discretion of the Administrator upon the occurrence of certain events as provided in this Agreement and Section 7 of the Plan.

5.3   Notices. Any notice to be given under the terms of this Agreement to the Company shall be addressed to the Company in care of the Secretary of the
Company at the address given beneath the signature of the Company's authorized officer on the Grant Notice, and any notice to be given to Participant shall be addressed to Participant at the
address given beneath Participant's signature on the Grant Notice. By a notice given pursuant to this Section 5.3, either party may hereafter designate a different address for notices to be given
to that party. Any notice that is required to be given to Participant shall, if Participant is then deceased, be given to the person entitled to exercise his or her Stock Option pursuant to Section 4.1
by written notice under this Section 5.3. Any notice shall be deemed duly given when sent via email or when sent by certified mail (return receipt requested) and deposited (with postage
prepaid) in a post office or branch post office regularly maintained by the United States Postal Service.

                                                       A-5

5.4   Titles. Titles are provided herein for convenience only and are not to serve as a basis for interpretation or construction of this Agreement.

5.5   Governing Law; Severability. The laws of the State of Nevada shall govern the interpretation, validity, administration, enforcement and performance of the
terms of this Agreement regardless of the law that might be applied under principles of conflicts of laws. Should any provision of this Agreement be determined by a court of law to be illegal or
unenforceable, the other provisions shall nevertheless remain effective and shall remain enforceable.

5.6   Conformity to Securities Laws. Participant acknowledges that the Plan, the Grant Notice and this Agreement are intended to conform to the extent
necessary with all provisions of the Securities Act of 1933, as amended, and the Exchange Act and any and all regulations and rules promulgated by the Securities and Exchange Commission
thereunder, and state securities laws and regulations. Notwithstanding anything herein to the contrary, the Plan shall be administered, and the Stock Option is granted and may be exercised,
only in such a manner as to conform to such laws, rules and regulations. To the extent permitted by applicable law, the Plan, the Grant Notice and this Agreement shall be deemed amended to
the extent necessary to conform to such laws, rules and regulations.

5.7   Tax Representations. Participant has reviewed with Participant's own tax advisors the federal, state, local and foreign tax consequences of this investment
and the transactions contemplated by the Grant Notice and this Agreement. Participant is relying solely on such advisors and not on any statements or representations of the Company or any
of its agents. Participant understands that Participant (and not the Company) shall be responsible for Participant's own tax liability that may arise as a result of this investment or the
transactions contemplated by this Agreement. 

5.8   Successors and Assigns. The Company may assign any of its rights under this Agreement to single or multiple assignees, and this Agreement shall inure
to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer herein set forth in Section 5.1, this Agreement shall be binding upon Participant and his or
her heirs, executors, administrators, successors and assigns.

5.9   Limitations Applicable to Section 16 Persons. Notwithstanding any other provision of the Plan or this Agreement, if Participant is subject to Section 16 of
the Exchange Act, the Plan, the Stock Option and this Agreement shall be subject to any additional limitations set forth in any applicable exemptive rule under Section 16 of the Exchange Act
(including any amendment to Rule 16b-3 of the Exchange Act) that are requirements for the application of such exemptive rule. To the extent permitted by applicable law, this Agreement shall
be deemed amended to the extent necessary to conform to such applicable exemptive rule.

5.10   Amendment, Suspension and Termination. To the extent permitted by the Plan, this Agreement may be wholly or partially amended or otherwise modified,
suspended or terminated at any time or from time to time by the Administrator; provided that, except as may otherwise be provided by the Plan, no amendment, modification,
suspension or termination of this Agreement shall alter the terms of the Stock Option so as to affect materially and adversely Participant's rights hereunder without the prior written consent of
Participant.

                                                       A-6

5.11   Electronic Delivery and Paperless Administration; Consent to Information Sharing.  By accepting this Stock Option, Participant hereby consents and
agrees to receive any and all documentation related to the Stock Option by electronic delivery and agrees to participate in the Plan through an online or electronic system, such as a system
using an internet website or interactive voice response, maintained by the Company or a third party designated by the Company.  In addition, in order to facilitate the administration of the
Company's equity administration by a third party, and for such third party administrator to provide reporting to the Company or its Affiliates on shares of Stock held within Participant's account
by such third party administrator, Participant hereby provides his or her consent on the sharing of this information by such third party administrator with the Company and its Affiliates.  The
foregoing consent shall lapse upon Participant's termination of Employment or his or her earlier revocation of such consent in writing to the Company.

   

   

   

   

                                                       A-7

EXHIBIT B

               TO STOCK OPTION GRANT NOTICE

FORM OF EXERCISE NOTICE

Effective as of today, _________, 20___ the undersigned ("Participant") hereby elects to exercise Participant's option to
purchase __________ shares of the Stock (the "Shares") of Seelos Therapeutics, Inc. (the "Company")
under and pursuant to the Seelos Therapeutics, Inc. 2019 Inducement Plan (the "Plan") and the Stock Option Grant Notice and Stock Option Agreement
dated _________, 20___, (the "Option Agreement"). Capitalized terms used herein without definition shall have the meanings given in the Option Agreement.

	
Grant Date:
	
___________________________________________________________

	
Number of Shares of Stock as to which Stock Option is Exercised:
	
___________________________________________________________

	
Exercise Price per Share of Stock:
	
$___________________________________________________________

	
Total Exercise Price:
	
$___________________________________________________________

	
Certificate to be issued in name of:
	
___________________________________________________________

	
Cash Payment delivered herewith:
	
$______________ (Representing the full Exercise Price for the Shares, as well as any applicable withholding tax)

 

Type of Option:           x 
    Non-Qualified Stock Option

1.Representations of Participant. Participant acknowledges that Participant has received, read and understood the Plan and the Option Agreement.
Participant agrees to abide by and be bound by their terms and conditions.

2.Rights as Stockholder. Until the Shares are issued (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer
agent of the Company), no right to vote or receive dividends or any other rights as a stockholder shall exist with respect to Shares subject to the Stock Option, notwithstanding the exercise of
the Stock Option. No adjustment will be made for a dividend or other right for which the record date is prior to the date the Shares are issued, except as provided in Section 7 of the Plan. The
Shares shall be freely tradeable and non-forfeitable. 

3.Tax Consultation. Participant understands that Participant may suffer adverse tax consequences as a result of Participant's purchase or disposition of
the Shares. Participant represents that Participant has consulted with any tax consultants Participant deems advisable in connection with the purchase or disposition of the Shares and that
Participant is not relying on the Company for any tax advice.

4.Successors and Assigns. This Agreement shall inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on
transfer herein set forth, this Agreement shall be binding upon Participant and his or her heirs, executors, administrators, successors and assigns.

5.Interpretation. Any dispute regarding the interpretation of this Agreement shall be submitted by Participant or by the Company forthwith to the
Administrator, which shall review such dispute at its next regular meeting. The resolution of such a dispute by the Administrator shall be final and binding on the Company and on
Participant.

6.Governing Law; Severability. This Agreement shall be governed by and construed in accordance with the laws of the State of Nevada, excluding
that body of law pertaining to conflicts of law. Should any provision of this Agreement be determined by a court of law to be illegal or unenforceable, the other provisions shall nevertheless
remain effective and shall remain enforceable.

7.Notices. Any notice required or permitted hereunder shall be given in accordance with the provisions set forth in Section 5.3 of the Option
Agreement.

8.Further Instruments. The parties agree to execute such further instruments and to take such further action as may be reasonably necessary to carry
out the purposes and intent of this Agreement.

	

ACCEPTED BY: 

SEELOS THERAPEUTICS, Inc.
	
SUBMITTED BY: 

PARTICIPANT

	 	 
	
By:
	__________________________________________	 	
By:
	 
	
Name:
	__________________________________________	 	
Name:
	__________________________________________
	
Title:
	
__________________________________________
	 	 	  
	
Address:
	
300 Park Ave. 12th Floor 
	 	
Address:
	__________________________________________

	
	
New York, NY 10022
	
	
	__________________________________________ASSET
PURCHASE AGREEMENT

 

THIS
ASSET PURCHASE AGREEMENT (this “Agreement”) is made as of August 6, 2019 (the “Effective
Date”), by and between Quantum Materials Corporation, a Nevada corporation (the “Buyer”),
and Capstan Platform, Inc., a Delaware corporation (the “Seller”). Each of the parties to this Agreement
will be referred to individually as a “Party” or jointly as the “Parties.”

 

RECITALS

 

WHEREAS,
the Seller is engaged in the business of creating, implementing, improving and maintaining an “Enterprise Trust Management”
solution using blockchain technologies to seamlessly and directly layer trust, security and immutability into files, folders and
workflows through the everyday tools designed for the knowledge worker (the “Business”).

 

WHEREAS,
the Seller wishes to sell to the Buyer, and the Buyer wishes to purchase from the Seller, certain assets of the Seller.

 

NOW,
THEREFORE, in consideration of the premises, the mutual covenants of the Parties hereinafter set forth and other good and
valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereto hereby agree as follows:

 

I.

PURCHASE
AND SALE

 

Section
1.1 Purchase and Sale of the Assets. Upon the terms and subject to the conditions of this Agreement, at the Closing, the
Seller shall assign, convey, deliver, sell and transfer to the Buyer all of the Seller’s right, title and interest, direct
or indirect, in and to all assets, properties and rights listed on Schedule 1.1 hereto (collectively, the “Purchased
Assets”), and the Buyer shall acquire and purchase the Purchased Assets from the Seller. The Buyer is not purchasing
any assets of the Seller other than the Purchased Assets or assuming any of the post-closing liabilities.

 

Section
1.2 Excluded Liabilities. The Buyer shall and does not assume or agree to discharge, pay, perform or satisfy (and the
Seller shall discharge, pay, perform, satisfy when due and otherwise retain without recourse to the Buyer) any and all liabilities
or obligations of the Seller whatsoever, whether direct or indirect, known or unknown, absolute or contingent, matured or unmatured,
and currently existing or hereinafter arising, including, without limitation, pre-closing tax liabilities (the “Excluded
Liabilities”). Without limiting the generality of the foregoing the Buyer is assuming no obligation for, and shall
have no responsibility with respect to, (a) any liability for any litigation matter or other third party claim to the extent arising
from the Purchased Assets or the conduct of the Seller or its business, regardless of whether such matter is disclosed herein,
in any Ancillary Agreement (as defined below) or on any Schedule hereto; (b) any liability for any claims by or relating to employees
or former employees of the Seller concerning acts or omissions of the Seller or otherwise, whether such acts or omissions occurred
prior to, on or after the Effective Date; (c) any liabilities of the Seller for any income or other tax obligations or for any
compensation or obligation under any employee benefit or incentive plan for the Seller’s employees or former employees or
both; (d) any liability under any employment severance retention or termination agreement with any employee of the Seller; and
(e) any liabilities under any Law (as defined below) regarding the protection of the environment, the protection of human health
or safety from the effects of contamination, hazardous materials or pollution or the arrangement for transport or disposal, clean-up,
disposal, distribution, existence, generation, handling, management, manufacture, presence, processing, production, reclamation,
recycling, release, remediation, reporting, reuse, storage, transport, treatment or use of hazardous materials.

 

Section
1.3 Consideration. In full consideration for the Purchased Assets, the Buyer shall pay to the Seller an aggregate amount
of $650,000, payable to the Seller by the issuance of
the shares (the “Shares”) of common stock, par value $0.001 per share, of the Company (the “Common
Stock”) described in Section 1.4(a)(ii)(C) and Section 1.4(b) below.

 

    	 	Page 1 of 11	 

    	 

    

 

Section
1.4 Closing and Payments.

 

(a)
Closing. The sale and purchase of the Purchased Assets shall take place at a closing (the “Closing”)
to be held at 10:00 a.m., Central time on the Effective Date, or at such other place or at such other time or on such other date
(the “Closing Date”) as the Seller and the Buyer mutually may agree in writing. At the Closing:

 

(i)
the Seller shall deliver to the Buyer the following:

 

	 	(A)	a bill
    of sale in the form attached hereto as Exhibit A (the “Bill of Sale,” and together will all
    other agreements, certificates and documents, the “Ancillary Agreements”) duly executed by the Seller;
    and
	 	 	 
	 	(B)	possession of the
    Purchased Assets; and

 

(ii)
the Buyer shall deliver to the Seller a certificate representing the a portion of the Shares determined by dividing $325,000 by
the average of the per-share closing price of the Common Stock for the five (5) trading days immediately preceding the Closing
Date, as reported on Yahoo! Finance or such other data source as the Buyer and the Seller may mutually agree.

 

(b)
Additional Payment of Purchase Price. On the sixty (60) day anniversary date of the Closing Date (the “Second
Payment Date”), the Buyer shall deliver to the Seller a certificate representing the a portion of the Shares determined
by dividing $325,000 by the average of the per-share closing price of the Common Stock for the five (5) trading days immediately
preceding the Second Payment Date, as reported on Yahoo! Finance or such other data source as the Buyer and the Seller may mutually
agree

 

ARTICLE
II

REPRESENTATIONS
AND WARRANTIES OF THE SELLER

 

The
Seller hereby represents and warrants to the Buyer on the date of the Closing as follows:

 

Section
2.1 Organization and Qualification. The Seller is a corporation duly organized, validly existing and in good standing
under the laws of the State of Delaware and has full power and authority to own, lease and operate the Purchased Assets and to
carry on the Business. The Seller is duly qualified or licensed as a foreign corporation to do business, and is in good standing,
in each jurisdiction where the ownership or operation of the Purchased Assets or the nature of the Business makes such qualification
or licensing necessary.

 

Section
2.2 Authority. The Seller has full power and authority to execute and deliver this Agreement and each of the
Ancillary Agreements to perform its obligations hereunder and thereunder and to consummate the transactions contemplated
hereby and thereby. The execution and delivery by the Seller of this Agreement and each of the Ancillary Agreements and the
consummation by the Seller of the transactions contemplated hereby and thereby have been duly and validly authorized by all
necessary corporate action on the part of the Seller. This Agreement has been, and upon their execution each of the Ancillary
Agreements to which the Seller will be a party will have been, duly executed and delivered by the Seller. This Agreement
constitutes, and upon their execution each of the Ancillary Agreements will constitute, the legal, valid and binding
obligations of the Seller, enforceable against the Seller in accordance with their respective terms, except as enforcement
may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar Laws (as defined below) affecting
creditors’ rights generally and by general principles of equity (regardless of whether considered in a proceeding in
equity or at Law).

 

    	 	Page 2 of 11	 

    	 

    

 

Section
2.3 No Conflict; Required Filings and Consents. The execution, delivery and performance by the Seller of this Agreement
and the Ancillary Agreements, and the consummation of the transactions contemplated hereby and thereby, do not and will not: (a)
conflict with or result in a violation or breach of, or default under, any provision of the charter or other organizational documents
of the Seller; (b) conflict with or result in a violation or breach of any provision of any federal, state or local statute, law,
regulation, order, injunction or decree (“Law”) applicable to the Seller, the Business or the Purchased
Assets; (c) require the consent, notice or other action by any Person (as defined below) under, conflict with, result in a violation
or breach of, constitute a default or an event that, with or without notice or lapse of time or both, would constitute a default
under, result in the acceleration of or create in any party the right to accelerate, cancel, modify or terminate any commitments,
contracts, deeds, indentures, instruments, joint ventures, leases, licenses, mortgages, notes, undertakings and all other agreements,
commitments and legally binding arrangements, whether written or oral, to which the Seller is a party or by which the Seller or
the Business is bound or to which any of the Purchased Assets are subject; (d) require the consent, notice or other action by
any Person under, conflict with, result in a violation or breach of, constitute a default or an event that, with or without notice
or lapse of time or both, would constitute a default under, result in the acceleration of or create in any party the right to
accelerate, cancel, modify or terminate any approvals, authorizations, certificates, franchises, licenses, permits, registrations,
variances and similar rights (a “Permit”) obtained, or required to be obtained, from any federal, state
or local governmental authority or any agency or instrumentality thereof (a “Governmental Authority”)
to which the Seller is a party or by which the Seller or the Business is bound or to which any of the Purchased Assets are subject;
(e) allow the imposition of any fees or penalties or require the offering or making of any payment to a third party on the part
of the Seller or the Business; or (f) result in the creation or imposition of any Encumbrance (as defined below) on the Purchased
Assets. No approval, consent, declaration, governmental order, Permit or filing with, or notice to, any Governmental Authority
is required by or with respect to the Seller in connection with the execution and delivery of this Agreement or any of the Ancillary
Agreements and the consummation of the transactions contemplated hereby and thereby.

 

Section
2.4 Title to Assets. The Seller has good and valid title to all of the Purchased Assets, free and clear of any charge,
claim, condition, encumbrance, lien, limitation, mortgage, security interest or other restriction of any kind (collectively, “Encumbrances”).
Pursuant to this Agreement and the Ancillary Agreements, the Buyer will acquire good and valid title to all of the Purchased Assets,
free and clear of any Encumbrance.

 

Section
2.5 Litigation. There is no action, arbitration, claim, inquiry, investigation, suit or other proceeding by or before
any administrative, arbitral, governmental, judicial or regulatory body (an “Action”) pending or threatened
(a) in connection with the Business or the Purchased Assets or the Seller’s ownership or operation thereof; (b) to restrain
or prevent the consummation of the transactions contemplated hereby; or (c) that might affect the right of the Buyer to own and
use the Purchased Assets, nor is there any basis for any of the foregoing. There is no outstanding award, decree, determination,
injunction, judgment, order or writ of, or pending or, to the knowledge of the Seller, threatened investigation by, any Governmental
Authority relating to the Business, the Purchased Assets, the Seller’s ownership or operation thereof or the transactions
contemplated by this Agreement or the Ancillary Agreements. There is no Action by the Seller pending, or which the Seller has
commenced preparations to initiate, against any other Person in connection with the Business or the Purchased Assets.

 

Section
2.6 Brokers. No broker, finder or agent will have any claim against the Buyer for any fees or commissions in connection
with the transactions contemplated by this Agreement based on arrangements made by or on behalf of the Seller.

 

    	 	Page 3 of 11	 

    	 

    

 

Section
2.7 Intellectual Property. The Seller does not own, license or use any copyrights, patents, service marks or trademarks,
and the possession of any copyright, patent, service mark or trademark is not required or necessary to conduct the Business in
the manner in which it has been conducted. The Seller has taken all reasonable steps to protect its rights in the intellectual
property rights constituting all or any portion of the Purchased Assets, including all trade secrets (collectively, the “Business
Intellectual Property”). The Seller owns all right, title and interest in and to, or possesses valid licenses or
other rights to use, all Business Intellectual Property. The Seller is not party to any agreement or arrangement that in any way
limits or restricts any Business Intellectual Property. The conduct by the Seller of the Business, including but not limited to
the creation and use of the Purchased Assets, to the best of Seller’s knowledge, has not infringed upon, misappropriated
or otherwise violated any intellectual property of any third party, and the Seller has not received any notice or claim with respect
to any such infringement, misappropriation or violation, nor is there any basis for any allegation thereof. To the Seller’s
knowledge, no third party is misappropriating, infringing or violating any intellectual property rights constituting all or any
portion of the Business Intellectual Property. The Seller has not granted any license with respect to any Business Intellectual
Property. No loss or expiration of any of the Business Intellectual Property is pending or reasonably foreseeable.

 

Section
2.8 Product Liability. There is no basis for any product liability, warranty or other claims by any third party arising
from the operation of the Business or the ownership of the Purchased Assets during the all periods through and including the Closing
Date.

 

Section
2.9 Compliance. The Seller has complied and is currently in compliance with all applicable Laws and Permits and is
not aware of any current violations, or past violations that have not been cured, of any such Laws or Permits. The Seller has
not received any notice with respect to the cancellation, suspension or termination of any of such Permits or the assessment of
any fines or penalties relating thereto, and to the knowledge of the Company, no cancellation, suspension or termination of any
of such Permits or the assessment of any fines or penalties relating thereto is threatened or imminent.

 

Section
2.10 Solvency. The Seller is not now insolvent and will not be rendered insolvent by any of the transactions contemplated
by this Agreement. As used herein, “insolvent” means that the sum of the debts and other probable liabilities of the
Seller exceeds the present fair saleable value of the Seller’s assets. Immediately after giving effect to the consummation
of the transactions contemplated by this Agreement: the Seller (a) will be able to pay its liabilities as they become due in the
usual course of its business; (b) will not have unreasonably small capital with which to conduct its present or proposed business;
(c) will have assets (calculated at fair market value) that exceed its liabilities; and (d) taking into account all pending and
threatened litigation, final judgments against the Seller in actions for money damages are not reasonably anticipated to be rendered
at a time when, or in amounts such that, the Seller will be unable to satisfy any such judgments promptly in accordance with their
terms (taking into account the maximum probable amount of such judgments in any such actions and the earliest reasonable time
at which such judgments might be rendered) as well as all other obligations of the Seller. The cash available to the Seller after
taking into account all other anticipated uses of the cash, will be sufficient to pay all such debts and judgments promptly in
accordance with their terms.

 

Section
2.11 Disclosure. None of the representations or warranties of the Seller contained in this Agreement or any of the
agreements, certificates, documents or other instruments contemplated by this Agreement, or any related exhibit or schedule hereto
or thereto, contains any untrue statement of a material fact or omits to state a material fact necessary to make the statements
herein or therein not misleading.

 

Section
2.12 Purchase for Own Account. The Shares will be acquired for the Seller’s own account, not as a nominee or
agent, and not with a view to or in connection with the sale or distribution of any part thereof.

 

    	 	Page 4 of 11	 

    	 

    

 

Section
2.13 Exempt from Registration; Restricted Securities. The Seller understands that the Shares have not been registered
under the Securities Act of 1933, as amended (the “Act”), the securities laws of any state thereof,
or the securities laws of any other jurisdiction, nor is such registration contemplated. The Seller understands that the Shares
will not be registered under the Act on the ground that the sale provided for in this Agreement is exempt from registration under
the Act, and that the reliance of the Buyer on such exemption is predicated in part on the Seller’s representations set
forth in this Agreement. The Seller understands that the Shares being issued hereunder are restricted securities within the meaning
of Rule 144 under the Act; that the Shares are not registered and must be held indefinitely unless they are subsequently registered
or an exemption from such registration is available.

 

Section
2.14 Restrictive Legends. It is understood that each certificate or other instrument, or any notation in the books
and records of the Buyer, representing the Shares and any other securities issued in respect of any of the foregoing upon any
stock split, stock dividend, recapitalization, merger, or similar event shall be stamped or otherwise imprinted with a legend
substantially in the following form:

 

THE
SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR
UNDER THE SECURITIES LAWS OF ANY STATES. THESE SECURITIES ARE SUBJECT TO RESTRICTIONS ON T R A N S F E R A B I L I T Y A N D R
E S A L E A N D M AY N O T B E TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER THE ACT AND THE APPLICABLE STATE SECURITIES LAWS,
PURSUANT TO REGISTRATION OR EXEMPTION THEREFROM. INVESTORS SHOULD BE AWARE THAT THEY MAY BE REQUIRED TO BEAR THE FINANCIAL RISKS
OF THIS INVESTMENT FOR AN INDEFINITE PERIOD OF TIME. THE ISSUER OF THESE SECURITIES MAY REQUIRE AN OPINION OF COUNSEL IN FORM
AND SUBSTANCE REASONABLY SATISFACTORY TO THE ISSUER TO THE EFFECT THAT ANY PROPOSED TRANSFER OR RESALE IS IN COMPLIANCE WITH THE
ACT AND ANY APPLICABLE STATE SECURITIES LAWS.

 

Section
2.15 No Transfer. The Shares to be acquired hereunder are being acquired by the Seller for the Seller’s own account,
not as a nominee or agent, for investment purposes only and not with a view to resale or distribution. The Seller has not entered
into any agreement, arrangement, contract or undertaking with any Person to pledge, sell or transfer to such Person the Shares
or otherwise grant to any Person any participation rights in the Shares (including rights to receive proceeds from distributions
made by or on behalf of the Buyer), and the Seller has no present plans or intentions to enter into any such agreement, arrangement,
contract or undertaking.

 

Section
2.16 Status. The Seller is an “accredited investor,” as defined in Regulation D under the Act. The Seller
has such knowledge and experience in financial and business matters that the Seller is capable of evaluating the merits and risks
of an investment in the Shares. The Seller is able to bear the economic risk of this investment. The Seller has had the opportunity
to consult with the Seller’s own attorney, accountant and/or purchaser representative regarding this investment in the Shares
and their suitability for purchase by the Seller, and to the extent necessary, the Seller has retained, at the Seller’s
own expense, and relied upon, appropriate professional advice regarding the investment, legal and tax merits, risks and consequences
of this Agreement and the other agreements, certificates, documents and instruments contemplated hereby and of purchasing and
owning the Shares.

 

Section
2.17 Transferability. The Seller is aware that there currently is no market for the Shares, that no such market may
ever develop and that it may not be possible to liquidate the Shares and the Buyer must bear the economic risks of the investment
in the Shares for an indefinite period of time.

 

    	 	Page 5 of 11	 

    	 

    

 

ARTICLE
III

REPRESENTATIONS
AND WARRANTIES OF BUYER

 

The
Buyer hereby represents and warrants to the Seller as follows:

 

Section
3.1 Organization and Qualification. The Buyer is a corporation duly organized, validly existing and in good standing
under the laws of the State of Nevada and has full power and authority to own, lease and operate its assets and to carry on its
business. The Buyer is duly qualified or licensed as a foreign corporation to do business, and is in good standing, in each jurisdiction
where the ownership or operation of its assets or the nature of its business makes such qualification or licensing necessary.

 

Section
3.2 Authority. The Buyer has full power and authority to execute and deliver this Agreement and each of the Ancillary
Agreements to perform its obligations hereunder and thereunder and to consummate the transactions contemplated hereby and thereby.
The execution and delivery by the Buyer of this Agreement and each of the Ancillary Agreements and the consummation by the Buyer
of the transactions contemplated hereby and thereby have been duly and validly authorized by all necessary corporate action on
the part of the Buyer. This Agreement has been, and upon their execution each of the Ancillary Agreements to which the Buyer will
be a party will have been, duly executed and delivered by the Buyer. This Agreement constitutes, and upon their execution each
of the Ancillary Agreements will constitute, the legal, valid and binding obligations of the Buyer, enforceable against the Buyer
in accordance with their respective terms, except as enforcement may be limited by applicable bankruptcy, insolvency, reorganization,
moratorium or similar Laws (as defined below) affecting creditors’ rights generally and by general principles of equity
(regardless of whether considered in a proceeding in equity or at Law).

 

Section
3.3 Shares. The Shares will have been duly authorized and, when issued paid in full in accordance with the terms set
out herein, will be duly issued, fully paid and nonassessable obligations of the Company.

 

Section
3.4 Brokers. No broker, finder or agent will have any claim against the Seller for any fees or commissions in connection
with the transactions contemplated by this Agreement based on arrangements made by or on behalf of the Buyer.

 

ARTICLE
IV

 COVENANTS

 

Section
4.1 Deliveries. On the Closing Date, the Seller will deliver or cause to be delivered to the Buyer all original
(and any and all copies of) agreements, documents, and books and records and all computer disks, records or tapes or any
other storage medium on which agreements, documents, books and records, files and other information relating to the Purchased
Assets are stored, in each case, that are in the possession or under the control of the Seller. Following the Closing Date,
the Seller shall not retain in its possession or under its control, in any form, any agreements, documents, or books and
records, or any computer disks, records or tapes or any other storage medium that contains copies of any agreements,
documents, books and records, files and other information relating to the Purchased Assets, including any of the foregoing
that is stored on any server or other storage media maintained by a Person on behalf of the Seller (including any
“cloud” storage platform). If, notwithstanding the foregoing, the Seller discovers following the Closing Date
that it is in possession of or has under its control any agreements, documents, or books and records or any computer disks,
records or tapes or any other storage medium on which any agreements, documents, books and records, files and other
information relating to the Purchased Assets are stored, the Seller shall (x) deliver to the Buyer any such information which
may not have been previously delivered pursuant to the first sentence of this Section 4.1 and (y) thereafter
permanently delete and erase all such information (including all copies thereof) in its possession or under its control as
soon as reasonably practicable.

 

    	 	Page 6 of 11	 

    	 

    

 

Section
4.2 Confidentiality. From and after the Closing, the Seller shall, and shall cause its Affiliates to, hold, and shall
use its reasonable best efforts to cause its representatives to hold, in confidence any and all information, whether written or
oral, concerning the Buyer, the Purchased Assets, this Agreement and the transactions contemplated hereby, except to the extent
that the Seller can show that such information (a) is generally available to and known by the public through no fault of the Seller,
any of its Affiliates or their respective representatives; or (b) is lawfully acquired by the Seller from and after the Closing
from sources which are not prohibited from disclosing such information by a contractual, fiduciary or legal obligation. If the
Seller or any of its Affiliates or their respective representatives are compelled to disclose any information by judicial or administrative
process or by other requirements of Law, the Seller shall promptly notify the Buyer in writing and shall disclose only that portion
of such information which the Seller is advised by its counsel in writing is legally required to be disclosed, provided that the
Seller shall use reasonable best efforts to obtain an appropriate protective order or other reasonable assurance that confidential
treatment will be accorded such information.

 

Section
4.3 Further Assurances. From time to time after the Closing Date, the Seller shall execute and deliver to the Buyer
such instruments of assignment, assurance, consent, conveyance, power of attorney, sale, transfer and other such instruments as
may be reasonably requested by the Buyer in order to vest in the Buyer all right, title, and interest in and to the Purchased
Assets. The Buyer and the Seller shall each provide the other with such assistance as reasonably may be requested by the other
in connection with the transfer and transition of the Purchased Assets and the preparation of any tax return, an audit or examination
of any such return by any taxing authority or any judicial or administrative proceeding relating to liability for taxes and shall
each retain and provide the other with any records or other information which may be relevant to such audit, examination, proceeding
or return.

 

Section
4.4 Consents and Filings. The Seller shall use all commercially reasonable efforts to take, or cause to be taken, all
appropriate action to do, or cause to be done, all things necessary, proper or advisable under applicable Law or otherwise to
consummate and make effective the transactions contemplated by this Agreement and the Ancillary Agreements as promptly as practicable,
including to (a) obtain from Governmental Authorities and other Persons all approvals, authorizations, consents, orders and qualifications
as are necessary for the consummation of the transactions contemplated by this Agreement and the Ancillary Agreements, (b) promptly
make all necessary filings, and thereafter make any other required submissions, with respect to this Agreement required under
any applicable Law and (c) have lifted, overturned, reversed or vacated any decree, injunction, judgement, order, ruling or other
action (whether temporary, preliminary or permanent) that is then in effect and that conditions, enjoins, makes illegal, restrains
or otherwise prohibits or restricts the consummation of the transactions contemplated by this Agreement and the Ancillary Agreements.
In furtherance and not in limitation of the foregoing, the Seller shall permit the Buyer reasonably to participate in the defense
and settlement of any Action relating to this Agreement or the transactions contemplated hereby, and the Seller shall not settle
or compromise any such Action without the Buyer’s written consent. Notwithstanding anything herein to the contrary, the
Buyer shall not be required by this Section to take or agree to undertake any action, including entering into any consent decree,
hold separate order or other arrangement, that would (i) require the divestiture of any assets of the Buyer or any of its Affiliates
or any portion of the Purchased Assets or (ii) limit the Buyer’s freedom of action with respect to, or its ability to consolidate
and control, the Purchased Assets or any of the Buyer’s or its Affiliates’ other assets or businesses.

 

    	 	Page 7 of 11	 

    	 

    

 

ARTICLE
V

INDEMNIFICATION

 

Section
5.1 Survival of Representations and Warranties. The representations and warranties of the Seller and the Buyer contained
in this Agreement and any schedule, certificate or other document delivered pursuant hereto or in connection with the transactions
contemplated hereby shall be continuing and survive the Closing until the end of applicable statute of limitations, provided,
however, that Section 2.1 (relating to organization and existence), Section 2.2 (relating to authority), Section
2.4 (relating to the Purchased Assets) and Sections 2.6 (relating to broker’s fees), and any representation in
the case of fraud, intentional breach or intentional misrepresentation, shall each survive indefinitely.

 

Section
5.2 Indemnification. The Seller shall save, defend, indemnify and hold harmless the Buyer and its Affiliates and the
respective representatives, successors and assigns of each of the foregoing from and against any and all awards, claims, costs,
damages, deficiencies, diminution of value, expenses, liabilities, losses, interest, judgments and penalties (including attorneys’
fees, costs and other out-of- pocket expenses incurred in investigating, preparing or defending the foregoing) (hereinafter collectively,
“Losses”), asserted against, incurred, sustained or suffered by any of the foregoing as a result of,
arising out of or relating to:

 

	 	(a)	any
    breach of any representation or warranty made by the Seller contained in this Agreement or any Ancillary Agreement or any
    appendix, attachment, certificate, exhibit, schedule or other document delivered pursuant hereto or thereto or in connection
    with the transactions contemplated hereby or thereby;
	 	 	 
	 	(b)	any breach of any
    covenant or agreement by the Seller contained in this Agreement or any Ancillary Agreement;
	 	 	 
	 	(c)	any of the Excluded
    Liabilities;
	 	 	 
	 	(d)	any and all taxes
    (including any interest, additions and penalties with respect thereto) imposed on the Buyer in connection with the Business
    or the Purchased Assets, or for which the Buyer is liable, with respect to all periods ending on or before the Closing Date,
    or a pro rata portion (based on an interim closing of the books) of any such taxes for any period that ends after but includes
    the Closing Date, and any costs or expenses with respect to tax indemnification arising hereunder; and
	 	 	 
	 	(e)	the Seller’s
    failure to comply with the terms and conditions of any bulk sales or bulk transfer or similar laws of any jurisdiction that
    may be applicable to the sale or transfer of any or all of the Purchased Assets to the Buyer.

 

Section
5.3 Procedures. Payment of amounts due under this indemnity shall be made promptly upon demand by the Buyer as and
when incurred by wire transfer of immediately available funds to an account designated in writing by the Buyer.

 

Section
5.4 Remedies Not Affected by Investigation, Disclosure or Knowledge. The Buyer hereby expressly reserves the right
to seek indemnity or other remedy for any Losses arising out of or relating to any breach of any agreement, covenant, promise,
representation or warranty contained herein, notwithstanding any investigation by, disclosure to, knowledge or imputed knowledge
of the Buyer or any of its representatives in respect of any fact or circumstances that reveals the occurrence of any such breach,
whether before or after the execution and delivery hereof. In furtherance of the foregoing, the Seller agrees that as knowledge
or lack of reliance shall not be a defense in law or equity to any claim of breach of any agreement, covenant, promise, representation
or warranty by the Seller herein, the Seller shall not in any proceeding concerning a breach or alleged breach of any agreement,
covenant, promise, representation or warranty herein, or any indemnity thereof, seek information concerning knowledge or reliance
of the Buyer or any of its Representatives, through deposition, discovery or otherwise or seek to introduce evidence or argument
in any proceeding regarding the knowledge or lack of reliance of the Buyer or any of its Representatives prior to the Closing
on or with respect to any such representations, warranties or covenants.

 

    	 	Page 8 of 11	 

    	 

    

 

Section
5.5 Prompt Payment. Payment of amounts due under this indemnity shall be made promptly upon the Buyer’s demand
as and when incurred by wire transfer of immediately available funds to an account designated in writing by the Buyer to the Seller.

 

ARTICLE
VI

GENERAL
PROVISIONS

 

Section
6.1 Successors and Assignment. This Agreement may not be assigned by either Party without the other Party’s prior
written consent.

 

Section
6.2 Amendments. This Agreement may not be altered, amended or modified except by a written instrument executed by all
Parties hereto.

 

Section
6.3 Notices. Any notices to be given hereunder by any Party to the other may be effected either by personal delivery
in writing, by mail, registered or certified, postage prepaid with return receipt requested, by facsimile or by e-mail. Notices
delivered personally shall be deemed communicated as of actual receipt; mailed notices shall be deemed communicated as of three
(3) days after mailing; facsimile and e-mail notices shall be deemed communicated one (1) business day after transmission, receipt
confirmed. Notices shall be addressed to the Parties at the addresses listed on the signature page to this Agreement. Each Party
may change its address or other information by written notice in accordance with this Section.

 

Section
6.4 Governing Law. This Agreement and any dispute arising from the performance or breach hereof shall be governed by
and construed and enforced in accordance with the laws of the State of Texas without reference to conflicts of laws principles.

 

Section
6.5 Enforcement of This Agreement. Any failure by a Party to take immediate action with respect to a breach of any
provision of this Agreement does not waive such Party’s right to act with respect to such breach or any other breach. Any
action or inaction by a Party in response to any breach of this Agreement does not limit such Party’s rights with respect
to actions it may take in response to any other similar or different type of breach.

 

Section
6.6 Severability. If any portion of this Agreement is found to be invalid or unenforceable by any court of competent
jurisdiction, the other provisions of this Agreement shall remain in full force and effect. Further, any provision of this Agreement
held invalid or unenforceable only in part or degree will remain in full force and effect to the extent not held invalid or unenforceable.

 

Section
6.7 Entire Agreement. This Agreement constitutes the entire agreement between the Parties with respect to the matters
set forth herein, and supersedes any prior agreement between the Parties with respect to the subject matter of this Agreement.
No Party has made any agreements, covenants, promises, representations or warranties relating to the subject matter of this Agreement
except as otherwise set forth herein, and any prior agreements or understandings not specifically set forth herein shall be of
no force or effect.

 

Section
6.8 Headings. Headings in this Agreement are for reference only and do not limit the scope or extent of such section.

 

Section
6.9 Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original,
but all of which together shall constitute one and the same instrument. Counterparts may be delivered via facsimile, electronic
mail or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and
be valid and effective for all purposes.

 

    	 	Page 9 of 11	 

    	 

    

 

Section
6.10 Fees and Expenses. Except as otherwise provided herein, all fees and expenses incurred in connection with or related
to this Agreement and the Ancillary Agreements and the transactions contemplated hereby and thereby shall be paid by the party
incurring such fees or expenses, whether or not such transactions are consummated.

 

Section
6.11 Third-Party Beneficiaries. Except as provided in Article V, nothing in this Agreement shall confer upon
any Person other than the Parties and their respective successors and permitted assigns any right of any nature.

 

Section
6.12 Enforcement. The Parties agree that irreparable damage would occur in the event that any of the provisions of
this Agreement were not performed in accordance with their specific terms or were otherwise breached. Accordingly, each of the
Parties shall be entitled to specific performance of the terms hereof, including an injunction or injunctions to prevent breaches
of this Agreement and to enforce specifically the terms and provisions of this Agreement in any court in the State of Texas, this
being in addition to any other remedy to which such Party is entitled at law or in equity. Each of the Parties hereby further
waives (a) any defense in any action for specific performance that a remedy at law would be adequate and (b) any requirement under
any law to post security as a prerequisite to obtaining equitable relief.

 

Section
6.13 Defined Terms.

 

(a)
“Affiliate” of a Person means any other Person that directly or indirectly, is controlled by, or is
under common control with, such Person. The term “control” (including the terms “controlled by”
and “under common control with”) means the possession, directly or indirectly, of the power to direct or cause the
direction of the management and policies of a Person, whether through the ownership of voting securities, by contract or otherwise.

 

(b)
“Person” means an individual or an association corporation, joint venture, Governmental Authority,
limited liability company, partnership, trust, unincorporated organization or other entity.

 

[Signature
page follows.]

 

    	 	Page 10 of 11	 

    	 

    

 

IN
WITNESS WHEREOF, the Parties have by duly authorized persons executed this Asset Purchase Agreement as of the date first written
above.

 

	 	Quantum
    Materials Corporation
	 	 	 
	 	By:	/S/ Stephen B.
    Squires
	 	Name:	Stephen Squires
	 	Title:	President and CEO
	 	 	 
	 	Address for Notices:
	 	 	 
	 	3055 Hunter Road
	 	

Attn:

 San Marcos, Texas 78666

Stephen Squires

	 	Email:	ssquires@qmcdots.com
	 	 	 
	 	Capstan
    Platform, Inc.
	 	 
	 	By	/S/
    Roy Truitt
	 	Name:	Capstan
    Platform, Inc
	 	Title:	Board
    Member
	 	 	 
	 	Address for Notices:
	 	401 Congress, Suite 1540, Austin TX 78701
	 	 
	 	 
	 	Attn:	 
	 	Email:	 

 

    	SIGNATURE PAGE TO ASSET PURCHASE AGREEMENT

    	 

    

 

SCHEDLE
1.1

PURCHASED
ASSETS

 

The
Capstan Trust Platform and all assets, business, claims and rights (of every character, description, kind and nature, whether
personal, real or mixed, whether tangible or intangible, whether accrued, contingent or otherwise, and wherever situated) arising
from, in connection with or related to the Capstan Trust Platform, together with all rights and privileges associated with such
assets, including in object and source code form, and including all past, current and in development releases and versions. The
Capstan Trust Platform is described on the attached “Overview.”

 

    	SIGNATURE PAGE TO ASSET PURCHASE AGREEMENT

    	 

    

 

EXHIBIT
A

 

BILL
OF SALE

 

    	SIGNATURE PAGE TO ASSET PURCHASE AGREEMENT

    	 

    

 

BILL
OF SALE

 

THIS
BILL OF SALE (this “Bill of Sale”) is made as of August 6, 2019 by and between Quantum Materials
Corporation, a Nevada corporation (the “Buyer”), and Capstan Platform, Inc., a Delaware corporation
(the “Seller”).

 

WHEREAS,
reference is made to that certain Asset Purchase Agreement, dated as of the date hereof (the “Agreement”),
by and between the Buyer and the Seller.

 

WHEREAS,
pursuant to the Agreement, the Seller has agreed to execute and deliver this Bill of Sale for the purpose of transferring to and
vesting in the Buyer title to the Purchased Assets as set forth herein.

 

Section
1. Conveyance.

 

(a)
Transfer. The Seller does hereby assign, convey, deliver, sell and transfer to the Buyer all of the Seller’s right,
title and interest, direct or indirect, in and to the Purchased Assets, free and clear of all Encumbrances, to have and to hold
the Purchased Assets by the Buyer, its successors and assigns, for its and their own use.

 

(b)
Transfer Power. The Seller hereby constitutes and appoints the Buyer and its successors and assigns, as the Seller’s
true and lawful attorney, with full power of substitution, in the Seller’s name and stead, on behalf of and for the benefit
of the Buyer and its successors and assigns, to demand and receive any and all of the Purchased Assets and to give receipts and
releases for and in respect of the Purchased Assets, or any part thereof, and from time to time to institute and prosecute in
the Seller’s name, for the benefit of the Buyer and its successors and assigns, any and all proceedings at law, in equity
or otherwise, which the Buyer and its successors and assigns, reasonably may require for the collection or reduction to possession
of any of the Purchased Assets.

 

Section
2. Relation to Agreement. This Bill of Sale documents the assignment, conveyance, delivery, sale and transfer contemplated
by the Agreement and is subject to all of the conditions, provisions and terms thereof. Nothing in this Bill of Sale shall constitute
a waiver of, expansion of or limitation upon any of the Seller’s or the Buyer’s rights and remedies under the Agreement
and, in the case of any conflict between the terms of the Agreement and this Bill of Sale, the Agreement shall govern.

 

Section
3. Successors and Assigns. This Bill of Sale shall be binding upon the Seller and their successors and permitted assigns
and shall inure to the benefit of the Buyer and its successors and assigns.

 

Section
4. Governing Law. This Bill of Sale and any dispute arising from the performance or breach hereof shall be governed
by and construed and enforced in accordance with the laws of the State of Texas without reference to conflicts of laws principles.

 

Section
5. Defined Terms. Capitalized terms used but not defined in this Bill of Sale shall have the meanings set forth in
the Agreement.

 

[Signature
page follows.]

 

    	SIGNATURE PAGE TO ASSET PURCHASE AGREEMENT

    	 

    

 

IN
WITNESS WHEREOF, the Seller has executed this Bill of Sale as of the date first written above.

 

	 	Capstan
    Platform, Inc.
	 	 	 
	 	By:	/S/ Roy Truitt
	 	Name:	Roy Truitt
	 	Title:	Board Member

 

    	SIGNATURE PAGE TO ASSET PURCHASE AGREEMENT

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00299-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00299-of-00352.parquet"}]]